enVVeno Medical Corporation (NVNO) Stock

Healthcare · Medical Devices · Member of Other US Stocks

enVVeno Medical Corporation (NVNO) closed at USD 7.40 on 2026-10-14, a change of -70.4 % over the past year, with a market capitalization of USD 5.51M.

enVVeno Medical Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

enVVeno Medical Corporation key figures

Previous close

USD 7.40 (2026-10-14)

1-year change

-70.4 %

Market cap

USD 5.51M

Enterprise value

USD -15.57M

P/E ratio (trailing)

-0.32

P/E ratio (forward)

-1.27

EPS (trailing)

-24.76

EPS (forward)

-6.22

PEG ratio

n/a

Price to book

0.26

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.47

Employees

33

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About enVVeno Medical Corporation

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for enVVeno Medical Corporation and compare it with other stocks.